BullishAgent BullishAgent
EDGAR Earnings Ratings Insiders Shorts
ETFs Screener Research
Sign in Register

PRPO

Precipio, Inc. NASDAQ Listed Jun 30, 2017
$25.26
+0.00% vs $25.26
Mkt Cap $40.5M
52w Low $12.05 65.0% of range 52w High $32.37
50d MA $25.52 200d MA $23.86
P/E (TTM) -52.2x
EV/EBITDA 40.2x
P/B 2.8x
Debt/Equity 0.2x
ROE -2.5%
P/FCF 112.9x
RSI (14) 80.40
ATR (14) $1.42
Beta 1.20
50d MA $25.52
200d MA $23.86
Avg Volume 31.3K
Precipio, Inc., a healthcare solutions company, provides diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages; HemeScreen, a suite of robust genetic diagnostic panels; ICE-COLD PCR, a proprietary and patented specimen technology that increases the sensitivity of molecular based tests; and COVID-19 antibody tests. It sells ICE-COLD-PCR technology kits to bio-pharma customers. Precipio, Inc. has collaborations with academic institutions specializing in cancer research, diagnostics, and treatment. The company is based in New Haven, Connecticut.
SIC Code
3826
CIK (SEC)
Phone
203 787 7888
4 Science Park · New Haven, CT 06511 · US
Data updated apr 26, 2026 8:49pm · Source: financialmodelingprep.com